Belvedere Trading’s Oscar Health OSCR Stock Holding History

Belvedere Trading’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,196	Closed	-$25.2K	–	1156
2026 Q1	$25.2K	Buy	+2,196	New	+$30.9K	﹤0.01%	622

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Belvedere Trading's OSCR Position: Q2 2026 in Review

Belvedere Trading sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 2,196 shares — an estimated $25.2K sold.

Belvedere Trading first reported a position in OSCR in Q1 2026 and held it in 1 quarter. The position peaked at $25.2K in Q1 2026. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

Belvedere Trading reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
Belvedere Trading sold 2,196 Oscar Health shares in Q2 2026, an estimated $25.2K.
Belvedere Trading first reported a position in Oscar Health in Q1 2026 and held it in 1 quarter.
Belvedere Trading's Oscar Health position peaked at $25.2K in Q1 2026.
402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Belvedere Trading's 13F filing for Q2 2026, filed 31 Jul 2026.